NASDAQ: MBBCMarathon Bancorp Inc Stock
$10.05-0.15 (-1.47%)
Updated Apr 30, 2025
MBBC Price
$10.05
Fair Value Price
-$1.36
Market Cap
N/A
52 Week Low
$9.90
52 Week High
$13.49
P/E
-67x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$6.55M
Earnings
-$319.26k
Gross Margin
100%
Operating Margin
-7.76%
Profit Margin
-4.9%
Debt to Equity
5.88
Operating Cash Flow
$486k
Beta
1.39
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MBBC Overview
Marathon Bancorp, Inc. focuses on to operate as a bank holding company for Marathon Bank, a chartered savings bank. Marathon Bank offers deposit products, such as demand deposits, savings, and certificates of deposits; and lending products comprising commercial real estate, commercial and industrial, construction, one-to-four-family residential, multi-family real estate, and consumer loans primarily in the Marathon County area of Wisconsin. The company was founded in 2020 and is based in Wausau, Wisconsin. Marathon Bancorp, Inc. operates as a subsidiary of Marathon MHC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MBBC's potential to beat the market
- MBBC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
MBBC
RankedUnranked of 294
RankedUnranked of 294
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $33.87 | B | |
| $33.91 | B | |
| $13.97 | B |
Be the first to know about important MBBC news, forecast changes, insider trades & much more!
MBBC News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MBBC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MBBC ($10.05) is overvalued by 839.9% relative to our estimate of its Fair Value price of -$1.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MBBC ($10.05) is not significantly undervalued (839.9%) relative to our estimate of its Fair Value price of -$1.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MBBC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MBBC due diligence checks available for Premium users.
Valuation
MBBC fair value
Fair Value of MBBC stock based on Discounted Cash Flow (DCF)
Price
$10.05
Fair Value
-$1.36
Undervalued by
839.90%
MBBC ($10.05) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MBBC ($10.05) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MBBC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MBBC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-67x
Industry
13.39x
Market
29.18x
MBBC's financial health
Profit margin
Revenue
$1.6M
Net Income
$51.1k
Profit Margin
3.2%
MBBC's Earnings (EBIT) of -$508.53k... subscribe to Premium to read more.
Interest Coverage Financials
MBBC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$217.9M
Liabilities
$186.2M
Debt to equity
5.88
MBBC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$113.6k
Investing
-$215.3k
Financing
$1.3M
MBBC's operating cash flow ($485.80k)... subscribe to Premium to read more.
Debt Coverage Financials
Marathon Bancorp Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.